← Back to patent-cliff list

CAS 13822-06-5

(R)-N-(2-(7-methoxy-1-methyl-2-methylene-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl)-3-methylbut-2-en-1-amine

Source drugs (routes using this intermediate)

DrugTierExpiry
PentazocineTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

PentazocineOptimised routesteps: 3total yield: 4.5 mg (Pentazocine)
(R)-2-(7-methoxy-1-methyl-2-methylene-1,2,3,4-tetrahydronaphthalen-1-yl)acetaldehyde→(R)-N-(2-(7-methoxy-1-methyl-2-methylene-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl)-3-methylbut-2-en-1-amine→(R)-N-(2-(7-methoxy-1-methyl-2-methylene-1,2,3,4-tetrahydronaphthalen-1-yl)ethyl)-3-methylbut-2-en-1-amine

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.